Table of Content

1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Scope
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (≥65)
1.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Trends (2016-2027)

2 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Forecasts by Region
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2016-2027)
2.4.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2016-2027)
2.4.6 India 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2016-2027)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Competition Landscape by Players
3.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Players by Sales (2016-2021)
3.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Players by Revenue (2016-2021)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2016-2021)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2022-2027)
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2016-2021)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2022-2027)

6 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
6.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company
6.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2021)
6.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021)
6.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type
6.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application
6.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2022-2027)

7 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company
7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2021)
7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type
7.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
8.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company
8.1.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2021)
8.1.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021)
8.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type
8.2.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2022-2027)
8.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
9.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company
9.1.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2021)
9.1.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021)
9.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type
9.2.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
10.1 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company
10.1.1 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)

11 India 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
11.1 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company
11.1.1 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2016-2021)
11.1.2 India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021)
11.2 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type
11.2.1 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2022-2027)
11.3 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application
11.3.1 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in 23-Valent Pneumococcal Polysaccharide Vaccine Business
12.1 MSD
12.1.1 MSD Corporation Information
12.1.2 MSD Business Overview
12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.1.5 MSD Recent Development
12.2 Sanofipasteur
12.2.1 Sanofipasteur Corporation Information
12.2.2 Sanofipasteur Business Overview
12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.2.5 Sanofipasteur Recent Development
12.3 CDIBP
12.3.1 CDIBP Corporation Information
12.3.2 CDIBP Business Overview
12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.3.5 CDIBP Recent Development
...

13 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
13.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
13.4 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
14.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers

15 Market Dynamics
15.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
15.2 23-Valent Pneumococcal Polysaccharide Vaccine Drivers
15.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
15.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Region (2016-2021)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Region (2016-2021)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Forecast by Region (2022-2027)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) of Key Companies (2016-2021)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Company (2016-2021)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Company (2016-2021)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2020)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2016-2021)
Table 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2016-2021)
Table 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Type (2016-2021)
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2022-2027)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2022-2027)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Type (2022-2027)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2016-2021)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2016-2021)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Application (2016-2021)
Table 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2022-2027)
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2022-2027)
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2022-2027)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose) by Application (2022-2027)
Table 38. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2016-2021)
Table 39. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 43. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 45. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 47. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 49. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2016-2021)
Table 51. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 55. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 57. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 59. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 61. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2022-2027)
Table 62. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2016-2021)
Table 63. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2021)
Table 64. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 67. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 68. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 69. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2022-2027)
Table 70. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 71. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 72. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 73. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2016-2021)
Table 75. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 79. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 81. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 83. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 85. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2016-2021)
Table 87. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 91. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 93. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 95. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 97. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2022-2027)
Table 98. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2016-2021)
Table 99. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2016-2021)
Table 100. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2016-2021) & (K Dose)
Table 103. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2016-2021)
Table 104. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2022-2027) & (K Dose)
Table 105. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2022-2027)
Table 106. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2016-2021) & (K Dose)
Table 107. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2016-2021)
Table 108. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2022-2027) & (K Dose)
Table 109. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2022-2027)
Table 110. MSD Corporation Information
Table 111. MSD Description and Business Overview
Table 112. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 114. MSD Recent Development
Table 115. Sanofipasteur Corporation Information
Table 116. Sanofipasteur Description and Business Overview
Table 117. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 119. Sanofipasteur Recent Development
Table 120. CDIBP Corporation Information
Table 121. CDIBP Description and Business Overview
Table 122. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 124. CDIBP Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 128. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 129. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Table 130. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Table 131. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 132. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. For Children (2-10) Examples
Figure 7. For Person (10-64) Examples
Figure 8. For The Old (≥65) Examples
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate (2016-2027)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate (2016-2027)
Figure 17. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine: 2016 & 2020
Figure 28. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2016-2021)
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2016-2021)
Figure 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 34. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 35. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 37. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 38. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 39. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 40. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 41. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 42. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 43. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020
Figure 44. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 47. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 48. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed